Active — Not RecruitingNot Applicable

Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function

France100 participantsStarted 2008-06

Plain-language summary

Anomalies of renal development are well know for patients treated for MODY-5 diabetes due to TCF2 mutation.A recent study confirms the existence of pediatric patients having TCF2 mutation but presenting renal anomalies alone.Endocrine and renal evolution of these patients is unknown.The aim of this study is to follow a cohort of patients with TCF2 mutation and initially presenting renal anomalies alone.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients presenting an anomaly of renal development due to TCF2 mutation * Age\<18 years old Exclusion Criteria: * Anomaly of renal development without TCF2 mutation * Age≥18 years old * Parents or patients refusing to participate to the study

Trial details

NCT IDNCT00760331

SponsorUniversity Hospital, Limoges

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2033-07

View on ClinicalTrials.gov More Hepatocyte Nuclear Factor 1-beta trials